The Effects of Methylphenidate on Goal-directed Behavior in a Rat Model of ADHD

Frontiers in Behavioral Neuroscience

Volumn 9, Issue , 2015, Pages

  Natsheh, Joman Y ^a,b   Shiflett, Michael W ^c  

^a RUTGERS UNIVERSITY   (United States)

^b AL QUDS UNIVERSITY   (Palestine)

^c Newark College of Arts and Sciences   (United States)

Author keywords

attention deficit hyperactivity disorder; goal directed behavior; methylphenidate; spontaneously hypertensive rats; Wistar Kyoto rats

Indexed keywords

EID: 84964643318     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2015.00326     Document Type: Article

References (55)

1. Arnsten A. F. (2011). Catecholamine influences on dorsolateral prefrontal cortical networks. Biological Psychiatry 15 e89–e99. 10.1016/j.biopsych.2011.01.027
2. Arnsten A. F. Dudley A. G. (2005). Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder. Behav. Brain Funct. 22 2. 10.1186/1744-9081-1-2
3. Barkley R. A. (2005). “Attention-Deficit Hyperactivity Disorder,” in A Handbook for Diagnosis and Treatment, 3rd Edn, ed. Barkley R. A. (New York: The Guilford Press), 770.
4. Berridge C. W. Devilbiss D. M. Andrzejewski M. E. Arnsten A. F. Kelley A. E. Schmeichel B. et al. (2006). Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol. Psychiatry 15 1111–1120. 10.1016/j.biopsych.2006.04.022
5. Brennan A. R. Arnsten A. F. (2008). Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function. Ann. N. Y. Acad. Sci. 1129 236–245. 10.1196/annals.1417.007
6. Bush G. Valera E. M. Seidman L. J. (2005). Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions. Biol. Psychiatry 1 1273–1284. 10.1016/j.biopsych.2005.01.034
7. Castellanos F. X. Tannock R. (2002). Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat. Rev. Neurosci. 3 617–628. 10.1038/nrn896
8. Clements K. M. Saunders A. J. Robertson B. A. Wainwright P. E. (2007). Spontaneously hypertensive, Wistar Kyoto and Sprague-Dawley rats differ in their use of place and response strategies in the water radial arm maze. Neurobiol. Learn. Mem. 87 285–294. 10.1016/j.nlm.2006.09.003
9. Clements K. M. Wainwright P. E. (2006). Spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats differ in performance on a win-shift task in the water radial arm maze. Behav. Brain Res. 28 295–304. 10.1016/j.bbr.2005.09.016
10. Davids E. Zhang K. Tarazi F. I. Baldessarini R. J. (2003). Animal models of attention-deficit hyperactivity disorder. Brain Res. Brain Res. Rev. 42 1–21. 10.1016/S0165-0173(02)00274-6
11. Dickinson A. (1985). Actions and habits: the development of behavioural autonomy. Phil. Trans. R. Soc. Lond. B. 308 67–78. 10.1098/rstb.1985.0010
12. Furukawa E. Bado P. Tripp G. Mattos P. Wickens J. R. Bramati I. E. et al. (2014). Abnormal striatal BOLD responses to reward anticipation and reward delivery in ADHD. PLoS ONE 9:e89129. 10.1371/journal.pone.0089129
13. Gauthier J. M. Tassin D. H. Dwoskin L. P. Kantak K. M. (2014). Effects of dopamine D1 receptor blockade in the prelimbic prefrontal cortex or lateral dorsal striatum on frontostriatal function in Wistar and Spontaneously Hypertensive Rats. Behav. Brain Res. 15 229–238. 10.1016/j.bbr.2014.04.018
14. Gill M. Daly G. Heron S. Hawi Z. Fitzgerald M. (1997). Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol. Psychiatry 2 311–313. 10.1038/sj.mp.4000290
15. Griffiths K. R. Morris R. W. Balleine B. W. (2014). Translational studies of goal-directed action as a framework for classifying deficits across psychiatric disorders. Front. Syst. Neurosci. 8:101. 10.3389/fnsys.2014.00101
16. Hammond L. J. (1980). The effect of contingency upon the appetitive conditioning of free-operant behavior. J. Exp. Anal. Behav. 34 297–304. 10.1901/jeab.1980.34-297
17. Heal D. J. Cheetham S. C. Smith S. L. (2009). The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. Neuropharmacology. 57 608–618. 10.1016/j.neuropharm.2009.08.020
18. Heal D. J. Smith S. L. Kulkarni R. S. Rowley H. L. (2008). New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD. Pharmacol. Biochem. Behav. 90 184–197. 10.1016/j.pbb.2008.03.016
19. Hill J. Herbst K. Sanabria F. (2012). Characterizing operant hyperactivity in the Spontaneously Hypertensive Rat. Behav. Brain Funct. 8 5. 10.1186/1744-9081-8-5
20. Hill R. (1970). “Facilitation of conditioned reinforcement as a mechanism of psychomotor stimulation,” in Amphetamines and Related Compounds, eds Costa E. Garattini S. (New York: Raven Press), 781–795.
21. Hitchcott P. K. Quinn J. J. Taylor J. R. (2007). Bidirectional modulation of goal-directed actions by prefrontal cortical dopamine. Cereb. Cortex 17 2820–2827. 10.1093/cercor/bhm010
22. Hynd G. W. Hern K. L. Novey E. S. Eliopulos D. Marshall R. Gonzalez J. J. et al. (1993). Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus. J. Child Neurol. 8 339–347. 10.1177/088307389300800409
23. Kantak K. M. Singh T. Kerstetter K. A. Dembro K. A. Mutebi M. M. Harvey R. C. et al. (2008). Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder. Behav. Neurosci. 122 340–357. 10.1037/0735-7044.122.2.340
24. Knardahl S. Sagvolden T. (1979). Open-field behavior of spontaneously hypertensive rats. Behav. Neural Biol. 27 187–200. 10.1016/S0163-1047(79)91801-6
25. Lex B. Hauber W. (2010). The role of dopamine in the prelimbic cortex and the dorsomedial striatum in instrumental conditioning. Cereb. Cortex 20 873–883. 10.1093/cercor/bhp151
26. Matsumoto K. Suzuki W. Tanaka K. (2003). Neuronal correlates of goal-based motor selection in the prefrontal cortex. Science 11 229–232. 10.1126/science.1084204
27. Matsumoto K. Tanaka K. (2004). The role of the medial prefrontal cortex in achieving goals. Curr. Opin. Neurobiol. 14 178–185. 10.1016/j.conb.2004.03.005
28. Mehta M. A. Calloway P. Sahakian B. J. (2000). Amelioration of specific working memory deficits by methylphenidate in a case of adult attention deficit/hyperactivity disorder. J. Psychopharmacol. 14 299–302. 10.1177/026988110001400314
29. Mehta M. A. Goodyer I. M. Sahakian B. J. (2004). Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. J. Child Psychol. Psychiatry Allied Discipl. 45 293–305. 10.1111/j.1469-7610.2004.00221.x
30. Mulder A. B. Nordquist R. E. Orgut O. Pennartz C. M. (2003). Learning-related changes in response patterns of prefrontal neurons during instrumental conditioning. Behav. Brain Res. 30 77–88. 10.1016/j.bbr.2003.09.016
31. Naneix F. Marchand A. R. Di Scala G. Pape J. R. Coutureau E. (2009). A role for medial prefrontal dopaminergic innervation in instrumental conditioning. J. Neurosci. 20 6599–6606. 10.1523/JNEUROSCI.1234-09.2009
32. Okamoto K. Aoki K. (1963). Development of a strain of spontaneously hypertensive rats. Jpn. Circul. J. 27 282–293. 10.1253/jcj.27.282
33. Ostlund S. B. Balleine B. W. (2005). Lesions of medial prefrontal cortex disrupt the acquisition but not the expression of goal-directed learning. J. Neurosci. 24 7763–7770. 10.1523/JNEUROSCI.1921-05.2005
34. Ostlund S. B. Winterbauer N. E. Balleine B. W. (2009). Evidence of action sequence chunking in goal-directed instrumental conditioning and its dependence on the dorsomedial prefrontal cortex. J. Neurosci. 24 8280–8287. 10.1523/JNEUROSCI.1176-09.2009
35. Robbins T. W. (1975). The potentiation of conditioned reinforcement by psychomotor stimulant drugs. A test of Hill’s hypothesis. Psychopharmacology 45 103–114.
36. Robbins T. W. (1978). The acquisition of responding with conditioned reinforcement: effects of pipradol, methylphenidate, d-amphetamine, and nomifensine. Psychopharmacology (Berl.) 58 79–87. 10.1007/BF00426794
37. Roessner V. Sagvolden T. Dasbanerjee T. Middleton F. A. Faraone S. V. Walaas S. I. et al. (2010). Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type. Neuroscience 2 1183–1191. 10.1016/j.neuroscience.2010.02.073
38. Russell V. (2003). Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder–the spontaneously hypertensive rat. Neurosci. Biobehav. Rev. 27 671–682. 10.1016/j.neubiorev.2003.08.010
39. Russell V. de Villiers A. Sagvolden T. Lamm M. Taljaard J. (1995). Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder–the spontaneously hypertensive rat. Brain Res. 10 343–351. 10.1016/0006-8993(95)00135-D
40. Sagvolden T. (2000). Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci. Biobehav. Rev. 24 31–39. 10.1016/S0149-7634(99)00058-5
41. Sagvolden T. Hendley E. D. Knardahl S. (1992)). Behavior of hypertensive and hyperactive rat strains: hyperactivity is not unitarily determined. Physiol. Behav. 52 49–57. 10.1016/0031-9384(92)90432-2
42. Sagvolden T. Johansen E. B. Aase H. Russell V. A. (2005a). A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav. Brain Sci. 28 397–419. 10.1017/S0140525X05000075 discussion 419–368,
43. Sagvolden T. Russell V. A. Aase H. Johansen E. B. Farshbaf M. (2005b). Rodent models of attention-deficit/hyperactivity disorder. Biol. Psychiatry 1 1239–1247. 10.1016/j.biopsych.2005.02.002
44. Sagvolden T. Pettersen M. B. Larsen M. C. (1993). Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains. Physiol. Behav. 54 1047–1055. 10.1016/0031-9384(93)90323-8
45. Schiffer W. K. Volkow N. D. Fowler J. S. Alexoff D. L. Logan J. Dewey S. L. (2006). Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Synapse 15 243–251. 10.1002/syn.20235
46. Tripp G. Wickens J. (2012). Reinforcement, dopamine and rodent models in drug development for ADHD. Neurotherapeutics 9 622–634. 10.1007/s13311-012-0132-y
47. Tripp G. Wickens J. R. (2008). Research review: dopamine transfer deficit: a neurobiological theory of altered reinforcement mechanisms in ADHD. J. Child Psychol. Psychiatry Allied Discipl. 49 691–704. 10.1111/j.1469-7610.2007.01851.x
48. Tripp G. Wickens J. R. (2009). Neurobiology of ADHD. Neuropharmacology 57 579–589. 10.1016/j.neuropharm.2009.07.026
49. Volkow N. D. Fowler J. S. Wang G. Ding Y. Gatley S. J. (2002). Mechanism of action of methylphenidate: insights from PET imaging studies. J. Atten. Disord. 6(Suppl. 1), S31–S43.
50. Waldman I. D. Rowe D. C. Abramowitz A. Kozel S. T. Mohr J. H. Sherman S. L. et al. (1998). Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am. J. Hum. Genet. 63 1767–1776. 10.1086/302132
51. Wilens T. E. (2008). Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J. Clin. Psychopharmacol. 28 S46–S53. 10.1097/JCP.0b013e318173312f
52. Wultz B. Sagvolden T. (1992). The hyperactive spontaneously hypertensive rat learns to sit still, but not to stop bursts of responses with short interresponse times. Behav. Genet. 22 415–433. 10.1007/BF01066613
53. Wultz B. Sagvolden T. Moser E. I. Moser M. B. (1990). The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior. Behav. Neural Biol. 53 88–102. 10.1016/0163-1047(90)90848-Z
54. Yin H. H. Knowlton B. J. Balleine B. W. (2004). Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. Eur. J. Neurosci. 19 181–189. 10.1111/j.1460-9568.2004.03095.x
55. Yin H. H. Ostlund S. B. Knowlton B. J. Balleine B. W. (2005). The role of the dorsomedial striatum in instrumental conditioning. Eur. J. Neurosci. 22 513–523. 10.1111/j.1460-9568.2005.04218.x